HOUSTON–(BUSINESS WIRE)–SynergenX, alongside its affiliated brands Low T Center and HerKare, today announced the launch of an expanded range of treatment options designed to give patients more flexibility, more choice, and more control over their care. These new offerings will be available across all clinic locations and through select telehealth services as of April, 2026.
The expanded lineup introduces new ways to address some of the most common concerns patients face, including low libido, hair loss, low testosterone, and weight management. New options include PT-141, an FDA-approved peptide therapy that supports libido in women; Minoxidil, an FDA-approved treatment for hair restoration; and Enclomiphene Citrate, an oral therapy that helps increase testosterone levels while preserving fertility. Patients will also have access to Sildenafil ODT and Tadalafil ODT, which use FDA-approved active ingredients to support sexual performance with both short-acting and longer-duration options.
Additional offerings include oral weight management treatments such as Semaglutide ODT and GLP-1/GIP ODT therapies. Wellness-focused treatments, including Vitamin D injections and Glutathione, are also available to support overall health, recovery, and immune function.
Together, these options create more personalized starting points for patients, including non-injection and non-hormonal approaches for those who may not be ready for traditional hormone therapy, allowing more patients to feel great, look great, and live their best lives.
“Our goal is simple: to do all we can to help patients feel like themselves again,” said Wayne Wilson, Founder and Chief Executive Officer of SynergenX. “By expanding the ways patients can begin treatment, we’re making care more approachable, more personalized, and easier to fit into everyday life.”
All treatments are delivered within a provider-led model that includes comprehensive testing, individualized treatment plans, and ongoing medical oversight. Patients can choose in-clinic care or convenient at-home options, depending on their needs.
This expansion reflects SynergenX’s continued commitment to meeting patients where they are and supporting long-term health, confidence, and quality of life.
For more information or to schedule a consultation, visit SynergenX.com.
Contacts
Media Contact:
Jordan Bailey
Marketing Communications Specialist, SynergenX / Low T Center
8326391569
[email protected]
